Author: clients_p17yrv

Article / 31.05.2022

Effective treatments for GBM remain a large unmet need in oncology. Developing an effective treatment is difficult due to many factors, including localization of tumors in the brain, resistance to therapy, migration of malignant cells into nearby brain tissue, and the blood-brain barrier. ...

Article / 05.05.2022

CAR T-cell therapy for blood cancers may provide long-term remission for some patients, but their clinical benefit is limited by the complexity and cost of manufacturing and lack of efficacy in solid tumors. New developments in the field, however, offer hope to patients of greater...

Article, Clinical Trial Research / 08.07.2021

MERIT’s CEO, Yijun Huang, PhD., shares his perspective about how big data impacts the pharma industry and the field of ophthalmology clinical trial research specifically. Read our article to discover three ways AI can assist in the field of image analysis for clinical trials....

Article / 08.07.2021

Clinical endpoint service providers offer a specific set of research services that revolve around a particular stage of clinical development or therapeutic area(s). Most providers increase value by helping you gain efficiencies and by providing deep scientific expertise with integrated services. With the top providers,...